Analyst recommended buying Mankind Pharma citing long buildup in derivatives and breakout above resistance

Tue 29 Sep 2026

Open interest change

7 percent

Volume

1 million shares

Resistance level

2,500 level

Current price

2,520

Target price

2,640 level

Heard on Live TV News Channel between 12:27:45 - 12:29:00 IST.

• Derivative data showed a long buildup with open interest up around 7% day on day.
• Stock picked up with strong volumes of around 1 million shares.
• Breaking out above recent resistance of 2,500 level, CMP at 2,520.
• Target set at 2,640 level, the recent high, with stop loss near 2,418 moving average.

The call above is Sundar Kewat, Ashika Institutional Equities's, reported here as they made it. Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.